A statement released earlier today by Zacks Investment Research about Manhattan Bridge Capital Inc. (NASDAQ:LOAN) bumps the target price to $6.75
- Updated: September 15, 2016
Indicating a possible upside of 0.10%, Zacks Investment Research bumped the target stock price of Manhattan Bridge Capital Inc. (NASDAQ:LOAN) to $7.
Just yesterday Manhattan Bridge Capital Inc. (NASDAQ:LOAN) traded 0.32% higher at $6.14. LOAN’s 50-day moving average is $5.96 and its two hundred day average is $4.92. With the last close up 27.51% from the 200-day moving average, compared with the S&P 500 Index which has fallen -0.01% over the same period. Trading volume was was up over the average, with 102,590 shares of LOAN changing hands over the typical 52,219 shares..
See Graph Below:
With a total market value of $0.0, Manhattan Bridge Capital Inc. has a 52 week low of $3.80 and a one-year high of $6.45 with a price-earnings ratio of 17.
About Manhattan Bridge Capital Inc. (NASDAQ:LOAN)
Manhattan Bridge Capital, Inc. (MBC) is a real estate finance company that specializes in originating, servicing and managing a portfolio of first mortgage loans. The Company offers short-term, secured, non-banking loans to real estate investors to fund their acquisition, renovation, rehabilitation or improvement of properties located in the New York metropolitan area. Its primary business objective is to grow its loan portfolio while protecting and preserving capital in a manner that provides for risk-adjusted returns to its shareholders over the long term through dividends. It intends to achieve this objective by continuing to selectively originate, fund loans secured by first mortgages on residential real estate held for investment located in the New York metropolitan area, and and to manage and service its portfolio in a manner designed to generate risk-adjusted returns across a range of market conditions and economic cycles. Its loan portfolio includes various construction loans.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.